Teri Loxam | Merck & Co., Inc. |
Kenneth C. Frazier | Merck & Co., Inc. |
Robert M. Davis | Merck & Co., Inc. |
Adam H. Schechter | Merck & Co., Inc. |
Roger M. Perlmutter | Merck & Co., Inc. |
Vamil K. Divan | Credit Suisse Securities (NYSE:USA) LLC |
Chris Schott | JPMorgan Securities LLC |
Jami Rubin | Goldman Sachs & Co. LLC |
Alex Arfaei | BMO Capital Markets (United States) |
Seamus Fernandez | Guggenheim Securities |
Andrew S. Baum | Citigroup Global Markets Ltd. |
Timothy Minton Anderson | Wolfe Research, LLC |
Umer Raffat | Evercore Group LLC |
David R. Risinger | Morgan Stanley & Co. LLC |
Good morning. My name is Darla, and I will be your conference operator today. At this time, I would like to welcome everyone to the Merck's Third Quarter 2018 Sales and Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session.